Vanguard Investments Australia, Ltd.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1550100
Victoria, C3
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,678,176
+$1,562,674 QoQ
Shares Held
45,557
-1.9% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#176
of 774 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vanguard Investments Australia, Ltd. holds $74,254,946 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
556,736 | $18,862,215 | |
| 2 | ZTS |
Zoetis Inc.
|
215,316 | $15,472,607 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
18,807 | $10,190,196 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
45,557 | $7,678,176 | |
| 5 | VTRS |
Viatris Inc
|
295,697 | $4,695,668 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
126,256 | $3,107,160 | |
| 7 | ALKS |
Alkermes plc.
|
39,928 | $2,092,227 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
16,736 | $1,856,691 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,678,176 | 45,557 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,115,502 | 46,421 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||